chr3-49890070-G-T
Position:
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BA1
The ENST00000296474.8(MST1R):c.3811-10C>A variant causes a splice polypyrimidine tract, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0755 in 1,589,556 control chromosomes in the GnomAD database, including 4,798 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (no stars).
Frequency
Genomes: 𝑓 0.074 ( 444 hom., cov: 32)
Exomes 𝑓: 0.076 ( 4354 hom. )
Consequence
MST1R
ENST00000296474.8 splice_polypyrimidine_tract, intron
ENST00000296474.8 splice_polypyrimidine_tract, intron
Scores
2
Splicing: ADA: 0.003578
2
Clinical Significance
Conservation
PhyloP100: 0.0650
Genes affected
MST1R (HGNC:7381): (macrophage stimulating 1 receptor) This gene encodes a cell surface receptor for macrophage-stimulating protein (MSP) with tyrosine kinase activity. The mature form of this protein is a heterodimer of disulfide-linked alpha and beta subunits, generated by proteolytic cleavage of a single-chain precursor. The beta subunit undergoes tyrosine phosphorylation upon stimulation by MSP. This protein is expressed on the ciliated epithelia of the mucociliary transport apparatus of the lung, and together with MSP, thought to be involved in host defense. Alternative splicing generates multiple transcript variants encoding different isoforms that may undergo similar proteolytic processing. [provided by RefSeq, Jan 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -13 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BP6
Variant 3-49890070-G-T is Benign according to our data. Variant chr3-49890070-G-T is described in ClinVar as [Benign]. Clinvar id is 3055583.Status of the report is no_assertion_criteria_provided, 0 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0863 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MST1R | NM_002447.4 | c.3811-10C>A | splice_polypyrimidine_tract_variant, intron_variant | ENST00000296474.8 | NP_002438.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MST1R | ENST00000296474.8 | c.3811-10C>A | splice_polypyrimidine_tract_variant, intron_variant | 1 | NM_002447.4 | ENSP00000296474 | P2 |
Frequencies
GnomAD3 genomes AF: 0.0741 AC: 11279AN: 152154Hom.: 444 Cov.: 32
GnomAD3 genomes
AF:
AC:
11279
AN:
152154
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0625 AC: 14276AN: 228480Hom.: 489 AF XY: 0.0629 AC XY: 7693AN XY: 122380
GnomAD3 exomes
AF:
AC:
14276
AN:
228480
Hom.:
AF XY:
AC XY:
7693
AN XY:
122380
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0756 AC: 108701AN: 1437284Hom.: 4354 Cov.: 32 AF XY: 0.0747 AC XY: 53208AN XY: 712376
GnomAD4 exome
AF:
AC:
108701
AN:
1437284
Hom.:
Cov.:
32
AF XY:
AC XY:
53208
AN XY:
712376
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0741 AC: 11285AN: 152272Hom.: 444 Cov.: 32 AF XY: 0.0718 AC XY: 5350AN XY: 74466
GnomAD4 genome
AF:
AC:
11285
AN:
152272
Hom.:
Cov.:
32
AF XY:
AC XY:
5350
AN XY:
74466
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
188
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
MST1R-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Dec 16, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
dbscSNV1_RF
Benign
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at